A randomized clinical trial in Pakistan evaluated whether structured, measurement-based care could accelerate antidepressant response and remission in adults with major depressive disorder compared with...
The FDA has approved a supplemental indication for lumateperone to reduce relapse risk in adults with schizophrenia based on phase 3 randomized withdrawal data.
A multinational cross-sectional survey of children and adolescents with moderate-to-severe atopic dermatitis found substantial disease burden, with distinct physical and psychosocial impacts by age group.
...
A large Finnish cohort study published in Neurology found that preinjury use of serotonergic antidepressants was not associated with increased 30-day mortality, emergency neurosurgical interventions, or...
A randomized clinical trial found that a 12-week web-based guided self-help program was noninferior to standard cognitive-behavioral therapy for reducing binge-eating episodes in adults with binge-eating...
Recent research found that soft drink consumption may be linked to major depressive disorder diagnosis and increased depressive symptom severity, with significant associations observed only among women.
...
A 3-year randomized trial found that older adults with untreated hearing loss who received a best-practice hearing intervention retained more diverse and robust social networks and reported less loneliness...
In an FDA panel held on July 21, 2025, experts discussed the nuances of risk-benefit counseling and stronger warnings for selective serotonin reuptake inhibitors (SSRIs) to ensure informed consent among...
A randomized controlled trial reveals that children with ADHD and ASD have distinct gut microbiota signatures, and that probiotic supplementation alters these profiles, offering promising insights for...
Amid rising rates of adolescent mental health issues, especially following the COVID-19 pandemic, primary care providers are uniquely positioned to identify and treat conditions like depression and anxiety...
